New Drugs for TB

Recent advancements in tuberculosis (TB) treatment include new drugs designed to improve effectiveness and reduce treatment duration. These drugs target bacteria more precisely, helping overcome resistance to older medications. Some, like bedaquiline and delamanid, are used for drug-resistant TB and work by interfering with the bacteria’s energy production, killing it more efficiently. These innovations aim to shorten therapy, lower side effects, and improve outcomes, especially in cases where traditional drugs fail. Overall, these new medications represent progress in TB control, providing hope for faster, safer, and more effective treatment options worldwide.